GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 98 filers reported holding GOSSAMER BIO INC in Q1 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,823 | -96.1% | 4,591 | -94.4% | 0.00% | – |
Q2 2023 | $98,009 | +9.0% | 81,674 | +14.5% | 0.00% | – |
Q1 2023 | $89,890 | -91.8% | 71,341 | -86.0% | 0.00% | -100.0% |
Q4 2022 | $1,102,021 | -100.0% | 507,844 | +120.3% | 0.00% | -50.0% |
Q3 2022 | $2,762,013,000 | +1864.3% | 230,552 | +1272.4% | 0.00% | – |
Q2 2022 | $140,608,000 | -34.8% | 16,799 | -32.4% | 0.00% | – |
Q1 2022 | $215,550,000 | -38.4% | 24,833 | -19.8% | 0.00% | – |
Q4 2021 | $350,192,000 | +86.1% | 30,963 | +106.8% | 0.00% | – |
Q3 2021 | $188,223,000 | +205.2% | 14,974 | +97.1% | 0.00% | – |
Q2 2021 | $61,680,000 | -67.0% | 7,596 | -62.4% | 0.00% | – |
Q1 2021 | $186,850,000 | +153.6% | 20,200 | +165.2% | 0.00% | – |
Q4 2020 | $73,666,000 | -55.4% | 7,618 | -42.8% | 0.00% | – |
Q3 2020 | $165,289,000 | +141.1% | 13,319 | +152.5% | 0.00% | – |
Q2 2020 | $68,562,000 | -69.4% | 5,274 | -76.1% | 0.00% | – |
Q1 2020 | $223,757,000 | +130.9% | 22,045 | +255.5% | 0.00% | – |
Q4 2019 | $96,922,000 | -17.0% | 6,201 | -10.9% | 0.00% | – |
Q3 2019 | $116,842,000 | +181.4% | 6,959 | +271.7% | 0.00% | – |
Q2 2019 | $41,521,000 | – | 1,872 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,370,000 | $4,044,000 | 0.97% |
Octagon Capital Advisors LP | 3,958,069 | $4,749,683 | 0.66% |
Palo Alto Investors LP | 3,465,152 | $4,158,182 | 0.34% |
NEA Management Company, LLC | 3,467,406 | $4,160,887 | 0.32% |
APIS CAPITAL ADVISORS, LLC | 180,000 | $216,000 | 0.22% |
Boxer Capital, LLC | 3,336,928 | $4,004 | 0.19% |
HHLR ADVISORS, LTD. | 4,974,041 | $5,968,849 | 0.13% |
Artal Group S.A. | 3,028,171 | $3,634 | 0.11% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,363,170 | $2,835,804 | 0.10% |
Birchview Capital, LP | 99,088 | $118,906 | 0.09% |